Treating cancer with a diabetes pill: Acarbose, an α-glucosidase inhibitor, suppresses the expression of Polypyrimidine Tract Binding Protein-1 (PTB1) via up regulation of its target gene, 15/May/2014, 10.06 am

Therapeutic insights into the treatment of glucose intolerance and insulin resistance: RREB [Ras responsive element (RRE) binding protein] protects against deficient ß-cell mass and function via down regulation of its target gene, 15/May/2014, 8.29 am
May 15, 2014
Tumorigenesis: E2F1 induces the expression of MDM2-ALT1, a stress-induced variant of MDM2, via up regulation of its target gene, 15/May/2014, 10.13 am
May 15, 2014
Show all

A study from Columbia University, New York, USA shows that HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA…” This study was published in the Jan, 2010 Nature by Prof. Dr Manley JLColumbia University, New York.

On the foundation of this interesting finding, Dr L Boominathan, Director-cum-chief Scientist of GBMD, reports here that: Treating cancer with a diabetes pill: Acarbose, an α-glucosidase inhibitor, suppresses the expression of Polypyrimidine Tract Binding Protein-1 (PTB1) via up regulation of its target gene

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathanTreating cancer with a diabetes pill: Acarbose, an α-glucosidase inhibitor, suppresses the expression of Polypyrimidine Tract Binding Protein-1 (PTB1) via up regulation of its target gene, 15/May/2014, 10.06 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Comments are closed.